These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

490 related items for PubMed ID: 26185093

  • 21. Immunoglobulins targeting both GPIIb/IIIa and GPIb/IX in chronic idiopathic thrombocytopenic purpura (ITP): evidence for at least two different IgG antibodies.
    Hou M, Stockelberg D, Kutti J, Wadenvik H.
    Br J Haematol; 1997 Jul; 98(1):64-7. PubMed ID: 9233565
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Autoantibody-mediated complement activation on platelets is a common finding in patients with immune thrombocytopenic purpura (ITP).
    Najaoui A, Bakchoul T, Stoy J, Bein G, Rummel MJ, Santoso S, Sachs UJ.
    Eur J Haematol; 2012 Feb; 88(2):167-74. PubMed ID: 21985182
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Management of idiopathic thrombocytopenic purpura (primary immune thrombocytopenia, ITP)].
    Kashiwagi H, Tomiyama Y.
    Rinsho Ketsueki; 2014 Oct; 55(10):2087-94. PubMed ID: 25297775
    [No Abstract] [Full Text] [Related]

  • 29. Fc-independent phagocytosis: implications for IVIG and other therapies in immune-mediated thrombocytopenia.
    Li J, van der Wal DE, Zhu L, Vadasz B, Simpson EK, Li C, Webster ML, Zhu G, Lang S, Chen P, Zeng Q, Ni H.
    Cardiovasc Hematol Disord Drug Targets; 2013 Mar 01; 13(1):50-8. PubMed ID: 23082940
    [Abstract] [Full Text] [Related]

  • 30. Platelet-associated anti-glycoprotein (GP) IIb-IIIa autoantibodies in chronic immune thrombocytopenic purpura mainly recognize cation-dependent conformations: comparison with the epitopes of serum autoantibodies.
    Kosugi S, Tomiyama Y, Shiraga M, Kashiwagi H, Mizutani H, Kanakura Y, Kurata Y, Matsuzawa Y.
    Thromb Haemost; 1996 Feb 01; 75(2):339-45. PubMed ID: 8815587
    [Abstract] [Full Text] [Related]

  • 31. Acquired Glanzmann thrombasthenia associated with platelet desialylation.
    Zheng SS, Perdomo JS, Leung HHL, Yan F, Chong BH.
    J Thromb Haemost; 2020 Mar 01; 18(3):714-721. PubMed ID: 31869497
    [Abstract] [Full Text] [Related]

  • 32. Idiopathic autoimmune thrombocytopenia: evidence for redistribution of platelet antibodies into the circulation after immunoadsorption treatment.
    Leitner GC, Stiegler G, Horvath M, Hoecker P, Sagaster P, Panzer S.
    Am J Hematol; 2003 May 01; 73(1):44-7. PubMed ID: 12701120
    [Abstract] [Full Text] [Related]

  • 33. Diminished expression of β2-GPI is associated with a reduced ability to mitigate complement activation in anti-GPIIb/IIIa-mediated immune thrombocytopenia.
    Zhu X, Zhang J, Wang Q, Fu H, Chang Y, Kong Y, Lv M, Xu L, Liu K, Huang X, Zhang X.
    Ann Hematol; 2018 Apr 01; 97(4):641-654. PubMed ID: 29350259
    [Abstract] [Full Text] [Related]

  • 34. Circulating antiplatelet antibody specificity in children with immune thrombocytopenic purpura at onset.
    Biglino P, Perutelli P, Mori PG.
    Haematologica; 1997 Apr 01; 82(1):127. PubMed ID: 9107104
    [No Abstract] [Full Text] [Related]

  • 35. Successful treatment with oseltamivir phosphate in a patient with chronic immune thrombocytopenia positive for anti-GPIb/IX autoantibody.
    Shao L, Wu Y, Zhou H, Qin P, Ni H, Peng J, Hou M.
    Platelets; 2015 Apr 01; 26(5):495-7. PubMed ID: 25166956
    [Abstract] [Full Text] [Related]

  • 36. Platelet autoantibody specificity and response to rhTPO treatment in patients with primary immune thrombocytopenia.
    Yu Y, Hou Y, Zhao Y, Zhou H, Jing F, Liu Y, Peng J, Liu X, Hou M.
    Br J Haematol; 2021 Jul 01; 194(1):191-194. PubMed ID: 33993469
    [Abstract] [Full Text] [Related]

  • 37. Performance characteristics of platelet autoantibody testing for the diagnosis of immune thrombocytopenia using strict clinical criteria.
    Gabe C, Sirotich E, Li N, Ivetic N, Nazy I, Smith J, Kelton JG, Arnold DM.
    Br J Haematol; 2021 Jul 01; 194(2):439-443. PubMed ID: 34109621
    [Abstract] [Full Text] [Related]

  • 38. [Study on the relations between HLA-DRB1 alleles and idiopathic thrombocytopenic purpura in children].
    Wang H, Shen B, Yan W, Hou M, Zhu N, Qi H, Hou H.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Aug 01; 19(4):290-4. PubMed ID: 12170464
    [Abstract] [Full Text] [Related]

  • 39. Immunodiagnosis of platelet activation in immune thrombocytopenia through scFv antibodies cognate to activated IIb3 integrins.
    Bhoria P, Varma N, Malhotra P, Varma S, Luthra-Guptasarma M.
    MAbs; 2015 Aug 01; 7(6):1212-20. PubMed ID: 26301697
    [Abstract] [Full Text] [Related]

  • 40. A role of autoantibody-mediated platelet destruction in thrombocytopenia in patients with cirrhosis.
    Kajihara M, Kato S, Okazaki Y, Kawakami Y, Ishii H, Ikeda Y, Kuwana M.
    Hepatology; 2003 Jun 01; 37(6):1267-76. PubMed ID: 12774004
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.